Du är här

Helena Ågerstam

Titel

PhD, laboratorieforskare

Organisation

Avdelningen för klinisk genetik

Telefon 046-2221584

E-post Helena [dot] Agerstam [at] med [dot] lu [dot] se

Publikationer (hämtat ur Lunds universitets publikationsdatabas)

författare

2013
- SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
- Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
2010
2009
- Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage
2007
- Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome.
2003
- HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects.

Visa detaljerad publikationslista

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen